EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myricitrin Alleviates Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease in High Cholesterol Diet-Fed Mice

Young-Je Kim, Sojeong Park, HwiCheol Kim, Sang Ryong Kim iD, Un Ju Jung iD

Nutrients · 2025

DOI: 10.3390/nu17030415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Young-Je Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, Kyungpook National University, Daegu 41566, Republic of Korea. Hauptthemen laut MEDLINE: Hypercholesterolemia, Non-alcoholic Fatty Liver Disease, Flavonoids, Diet. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: a Research Grant of Pukyong National University, Pukyong National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: This research investigated the effects of myricitrin on hypercholesterolemia and non-alcoholic fatty liver disease (NAFLD) in mice given a high-cholesterol diet (HCD).

Methods

C57BL/6J mice were maintained for 20 weeks on an HCD with or without myricitrin.

Results

Myricitrin had no impact on the food consumption, body weight, or plasma triglyceride concentrations. However, myricitrin-supplemented mice had lower plasma total cholesterol (TC) concentrations and LDL + VLDL-cholesterol/TC proportion, and higher HDL-cholesterol/TC proportion than control mice, which resulted in a markedly decreased atherogenic index. Moreover, the levels of plasma C-reactive protein, oxidized LDL, lipoprotein(a), and plasminogen activator inhibitor-1, which are indicators for cardiovascular disease (CVD), were reduced, while levels of plasma paraoxonase, a cardioprotective enzyme, were greater in myricitrin-supplemented mice than in control mice. Myricitrin also meaningfully reduced liver weight and hepatic cholesterol content, and slightly alleviated fatty liver and fibrosis caused by an HCD. The plasma and hepatic cholesterol-lowering effects of myricitrin were partly associated with decreased activities of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase and acyl-CoA:cholesterol acyltransferase, which are involved in cholesterol synthesis and esterification, respectively, as well as mRNA expression. Myricitrin also altered other hepatic genes implicated in cholesterol homeostasis, including the downregulation of SREBP2 and ABCA1 mRNA expression and the upregulation of LDLR mRNA expression. Moreover, myricitrin decreased TBARS levels in the liver and erythrocytes by activating antioxidant enzymes (SOD and catalase).

Conclusions

These results indicate that dietary myricitrin may offer therapeutic benefits for HCD-caused hypercholesterolemia and NAFLD, and may help reduce CVD risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaNon-alcoholic Fatty Liver DiseaseFlavonoidsDietCholesterol, DietaryAnticholesteremic AgentsMice, Inbred C57BLAnimalsMiceDisease Models, AnimalDietary SupplementsCholesterolLiver

Stichwörter der Autor:innen

high-cholesterol diethypercholesterolemiamyricitrinnon-alcoholic fatty liver disease

Substanzen

myricitrinFlavonoidsCholesterolCholesterol, DietaryAnticholesteremic Agents

Autor:innen und Institutionen

  • Department of Food Science and Nutrition, Kyungpook National University, Daegu 41566, Republic of Korea.
  • Department of Food Science and Nutrition, Pukyong National University, 45 Yongso-ro, Nam-gu, Busan 48513, Republic of Korea.
  • School of Life Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.

ORCID-Profile: Sang Ryong Kim, Un Ju Jung

Förderung

  • a Research Grant of Pukyong National University
  • Pukyong National University

Zitieren

APA

Kim, Y. J., Park, S., Kim, H., Kim, S. R., & Jung, U. J. (2025). Myricitrin Alleviates Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease in High Cholesterol Diet-Fed Mice. Nutrients. https://doi.org/10.3390/nu17030415

Vancouver

Kim YJ, Park S, Kim H, Kim SR, Jung UJ. Myricitrin Alleviates Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease in High Cholesterol Diet-Fed Mice. Nutrients. 2025. doi:10.3390/nu17030415

BibTeX
@article{Kim2025,
  author = {Kim, Young-Je and Park, Sojeong and Kim, HwiCheol and Kim, Sang Ryong and Jung, Un Ju},
  title = {Myricitrin Alleviates Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease in High Cholesterol Diet-Fed Mice},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17030415}
}
Kostenlos starten →